Patient Name;, 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.: THI No.:
Lab. Reference:  Provider: 
Addressee:
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): THYROID FUNCTION TEST (TFT-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

THYROID PROFILE


Specimen Type: Serum

TSH (0.5-4.0) miIU/L 0.73 0.82 0.64 0.46

FT4 (10-20) pmol/L 15 13 13

FT3 (3.5-6.0) pmol/L 4.8

Please note marginally low TSH. This may be a variation of normal or may
be an early phase of thyroid dysfunction. Suggest follow up review with
TFTs as clinically appropriate.

Requested Tests : VBF, UMM, TFT, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE, DVI,
COR





Date Requested: 10/12/2018 Date Performed: 10/12/2018

Date Collected: 10/12/2018 Complete: Final

Specimen:

Subject(Test Name): VITAMIN D (DVI-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin
VITAMIN D

Serum 25(0OH) Vitamin D 108 nmol/L

Suggested decision limits for Vitamin D status:

Sufficiency 51 -200 nmol/L
Mild deficiency 25 - 50 nmol/L
Marked deficiency < 25 nmol/L
Toxicity >250 nmol/L

References: Vitamin:-D and health in adults in Australia and New Zealand:
Position Statement. MJA 2012 June 18; 196(11),686-687.

Requested Tests : VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE,
DVI, COR

Patient Name:
Patient Address:

D.O.B:
Medicare No.: THI No.:
- Lab. Reference: 
Addressee: 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): SERUM CORTISOL (COR-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin
SERUM CORTISOL

Time 15:36
Cortisol 188 nmol/L

PM Reference Interval 100-400 nmol/L

Requested Tests : VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE,
DVI*, COR

Patient Name: 
Patient Address; 

D.O.B: 
Medicare No.: 
Lab. Reference: 
Addressee:  Referred by; 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): IRON STUDIES (FE-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

IRON STUDIES

Request Number 
Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 10:45 14:45 12:05 15:36

Specimen Type: Serum

Iron (10-30) umol/L 40 33 21 27

T' ferrin (32-48) umol/L 24 20 21 22

T. Sat. (13-45) % 85 84 51 63

Ferritin (30-400) ug/L 63 110 115 44

Monitoring of haemochromatosis noted. Current guidelines recommend
maintaining ferritin levels between 50 and 100 ug/L. (AASLD. Hepatology
2011; 54:328-43).

Requested Tests’: VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE, FBE,
DVI*, COR*

Patient Name; 

Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  IHI No.:

Lab. Reference: 
Addressee: 

Date Requested: 10/12/2018 Date Performed:, 10/12/2018

Date Collected: 10/12/2018 | Complete: Final
Specimen:
Subject(Test Name): PARATHYROID HORMONE (PTH-0)

Clinical Information:

Clinical Notes :

For review with elevated prolactin

PARATHYROID HORMONE

Request Number
Date Collected

11744628 14721343
30 Apr 18 10 Dec 18

Time Collected 12:05 15:36
Specimen Type: Plasma
iPTH (1.5-9.9) pmol/L 8.3 9.0

Results do not suggest a parathyroid disorder.

Requested Tests :

DVI*, COR*

VBF, UMM, TFT*, TAA, PRL, PTH, ESR, CRP, CEA, C19, C15, 125, MBA, FE*

e

FBE,

Patient Name: 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  THI No.:
Lab. Reference: 
Addressee: 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): THYROID AUTOANTIBODIES (TAA-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin
THYROID AUTOANTIBODIES
Specimen Type: Serum

Anti-Thyroglobulin Abs (Immulite) 110 TU/mL (< 41)
Anti-Thyroidal Peroxidase Abs 332 U/mL (< 60)

Over 90% of patients with autoimmune thyroiditis show moderate to high
levels of Anti-Thyroidal Peroxidase Abs (anti-TPO) with
Anti-Thyroglobulin Abs (anti-Tg) also present in about 90% of such
patients. Up to 75% of patients with Graves' hyperthyroidism show
increased anti-TPO with anti-Tg present in 50-60%. Low levels of both
anti-TPO and anti-Tg may be found in up to 10% of "normal" asymptomatic
adults. In most cases of autoimmune thyroid disease increased anti-TPO is
the predominant finding although a small proportion of patients show a
predominant increase in anti-Tg.

Requested Tests : VBF, UMM, TFT*, TAA, PRL, PTH*, ESR, CRP, CEA, C19, C15, 125, MBA, FE*, FBE,
DVI*, COR*

Patient Name: 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  THI No.:
Lab. Reference: 
Addressee: 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): SERUM C.E.A (CEA-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

SERUM CARCINO EMBRYONIC ANTIGEN

Request Number 28473096 10809027 11744628 14721343
Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 12:55 14:45 12:05 15:36

CEA (Bayer) (< 2.6) ug/L 4.2 3.4 4.1 3.4

CEA concentrations may increase due to benign conditions, including liver
disease, renal failure, pancreatitis and inflammatory bowel disease.
Smoking may also increase CEA concentrations. CEA measurement has been
recommended for the ongoing monitoring and surveillance of patients with
known neoplasia. The test has insufficient sensitivity and specificity
for diagnostic utility.

Requested Tests : VBF, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA, C19, C15, 125, MBA, FE*, FBE,
DVI*, COR*

Patient Name; 

Patient Address: 
D.O.B: 24/09/1932 Gender: F
Medicare No.:  IHI No.:

Lab. Reference: 
Addressee: 

Date Requested: 10/12/2018 Date Performed: 10/12/2018

Date Collected: 10/12/2018 Complete: Final

Specimen:

Subject(Test Name): CARBOHYDRATE ANTIGEN 19-9 (C19-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

SERUM CANCER ANTIGEN 19.9

Request Number 28473096 10809027 11744628 14721343
Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collectd 12:55 14:45 12:05 15:36
CA-19.9 (< 37) U/mL 10 5.0 6.0 7.0

(Bayer Centaur)

Requested Tests : VBF, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19, C15, 125, MBA, FE*, FBE,
DVI*, COR*

Patient Name: 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  THI No.:
Lab. Reference: 
Addressee: DRINNA LIEB Referred by: DR. INNA LIEB
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): CANCER ANTIGEN 125 (125-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

SERUM CANCER ANTIGEN 125

Request Number 28473096 10809027 11744628 14721343
Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 12:55 14:45 12:05 15:36

CA125 (< 35) U/mL 17 11 15 13

Requested Tests : VBF, UMM, TET*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125, MBA, FE*
FBE, DVI*, COR*

Patient Name; 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  THI No.:
Lab. Reference: 
Addressee: 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 | Complete: Final
Specimen:

Subject(Test Name): B12, FOLATE, R.C.FOLATE (VBF-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

VITAMIN Bl2 AND FOLATE STUDIES

Request Number 28473096 10809027 11744628 14721343
Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 12:55 14:45 12:05 15:36

B12 (301-740) pmol/L 252 408 860 537

Active B12 (> 36) pmol/L > 128

Serum Folate (> 9.0)nmol/L 23.1 23.2 25.0 33.6

Folate Interpretation:

| | DEFICIENCY | BORDERLINE | SUFFICIENCY |
| pre nen enn nee pon--- +--+ $----------~-------+- $o-ee--------- |
| Serum Folate: | <4.5 nmol/L | 4.5 - 9.0 nmol/L | >9.0 nmol/L |
| --------------- $------------- $-—----------------- $o---+-------- |
| RBC Folate: | <340 nmol/L | 340 - 570 nmol/L | >570 nmol/L |

Serum Folate Assay:
In the absence of recent oral intake, a serum folate >9.0 nmol/L
effectively rules out folate deficiency.

Please note that Medicare requirements for folate testing reflect current
best practice. Red cell folate will be reserved for patients with
borderline values for serum folate (between 4.5 and 9.0 nmol/L.)

Requested Tests : VBF, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125*, MBA, FE*
FBE, DVI*, COR*

Patient Name: 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  THI No.:
Lab. Reference: 
Addressee: 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): SERUM CHEMISTRY (MBA-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

SERUM CHEMISTRY

Request Number 10289756 10809027 11744628 14721343
Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 10:45 14:45 12:05 15:36

Specimen Type: Serum

Haemolysis Nil Nil Nil Nil

Icterus Nil Nil Nil Nil

Lipaemia Nil Nil Nil Nil

Na (135-145) mmol/L 140 142 138 138

K (3.6-5.4) mmol/L 4.5 4.0 3.8 4.2

Cl (95-110) mmol/L 106 108 101 106
HCO3 (22-32) mmol/L 24 24 26 25
An Gap (10-20) mmol/L 14 14 15 11
Urea (3.0-10.0) mmol/L 6.5 5.7 2.3 6.7
Creat (45-90) umol/L 45 55 40 55
eGFR mL/min/1.73m*2 88 83 > 90 81
Urate (0.14-0.36) mmol/L 0.28 0.14 0.21
Bili (< 15) umol/L 13 13 10 9
AST (< 35) U/L 25 26 26 19
ALT (< 30) U/L 20 17 17 13
GGT (< 35) U/L 11 12 12 12
Alk Phos (30-115) U/L 65 60 70 62
Protein (60-82) g/L 69 63 68 65
Albumin (36-48) g/L 41 39 43 41
Glob (20-39) g/L 28 24 25 24
Ca (2.10-2.60) mmol/L 2.39 2.43 2.41 2.41
Corr Ca (2.10-2.60) mmol/L 2.43 2.51 2.41 2.45
PO4 (0.75-1.50) mmol/L 1.00 1.95 1.01 1.24
CPK (< 211) U/L 160 64 68
Amylase (< 121) U/L 55 57 73
Lipase (6-70) U/L 32 29 38
Mg (0.70-1.10) mmol/L 0.82 0.86 0.90

eGFR values between 60 and 89 mL/min/1.73m2 should be interpreted with
caution. These results are only consistent with CKD in the presence of
other evidence such as microalbuminuria, proteinuria or haematuria.
Ref:Lamb EJ etal in Ann Clin Biochem 2005; 42:321-345.

Requested Tests : VBF*, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125*, MBA, FE*
FBE, DVI*, COR*

Patient Name: 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  IHI No.:
Lab. Reference: 
Addressee: DRINNA LIEB Referred by: DR. INNA LIEB
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): SERUM PROLACTIN (PRL-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

PROLACTIN

Specimen Type: Serum

Request Date Prolactin
Number Collected mIU/L

Ref Range (40-570)

24623334 01/11/16 114
28473096 07/06/17 84
10289756 12/09/17 90
10809027 08/11/17 121
12519902 25/05/18 78
14721343 10/12/18 92

Requested Tests : VBF*, UMM, TFT*, TAA*, PRL, PTH*, ESR, CRP, CEA*, C19*, C15, 125*, MBA, FE*,
FBE, DVI*, COR*

Subject(Test Name):

Patient Name:
Patient Address:

D.O.B: 24/09/1932

Medicare No.:
Lab. Reference:
Addressee:

Date Requested
Date Collected
Specimen



: 10/12/2018
: 10/12/2018

Clinical Information:

Clini

cal Notes :

Request Number

Date
Time
Spe
CRP

Requ
FBE,

Collected
Collected







Date Performed:

C-REACTIVE PROTEIN (CRP-0)

For review with elevated prolactin

C-REACTIVE PROTEIN
10809027 11744628

7 Jun 17

cimen Type: Serum

(< 6.0)

ested Tests
DVI*, COR*

mg/L

: VBF*, UMM,

28473096
12:55
< 4.0

TFET*, TAA*,

8 Nov 17

14:45
< 4.0

PRL*, PTH*,

‘ Gender:

F

JHI No.:

Provider:
Referred by:

Laverty Pathology
DR. INNA LIEB

10/12/2018

Complete: Final

30 Apr 18

12:05

< 4.0

14721343
10 Dec 18
15:36

< 4.0

ESR, CRP, CEA*, C19*,

C15,

125*,

MBA*,

FE*

t

Patient Name: 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  THI No.:
Lab. Reference: 
Addressee: 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
‘Date Collected: 10/12/2018. Complete: Final
Specimen:

Subject(Test Name); CARBOHYDRATE ANTIGEN 15-3 (C15-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

SERUM CANCER ANTIGEN 15.3

Request Number 28473096 10809027 11744628 14721343

Date Collected 7 Jun 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 12:55 14:45 12:05 15:36
CA-15.3 (< 39) U/mL 17 12 20 18

(Bayer Centaur)

Requested Tests : VBF*, UMM, TET*, TAA*, PRL*, PTH*, ESR, CRP*, CEA*, C19*, C15, 125*, MBA*
FE*, FBE, DVI*, COR*

Patient Name: 
Patient Address: 

D.O.B: 24/09/1932 Gender: F
Medicare No.;  THI No.:
Lab. Reference: 
Addressee: 
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): URINE MICRO/CULTURE (UMM-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

URINE EXAMINATION

Specimen Midstream
CHEMISTRY ; MICROSCOPY

pH 6.5 Leucocytes 5 x10°6 /L (< 10)
Protein nil Erythrocytes 46 x10*6 /L (< 10)
Glucose nil Epithelial cells 2 x10°6 /L (< 10)
Blood +

A urine with these results is not usually infected. Although culture has
been performed, a further report will only be issued if the culture is
positive.

Haematuria noted.

Requested Tests : VBF*, UMM, TFT*, TAA*, PRL*, PTH*, ESR, CRP*, CEA*, C19*, Ci5*, 125*, MBA*
FE*, FBE, DVI*, COR*

Patient Name; 
Patient Address; 

D.O.B: 24/09/1932 Gender: F
Medicare No.:  THI No.:
Lab. Reference: 
Addressee: DRINNA LIEB Referred by: DR. INNA LIEB
Date Requested: 10/12/2018 Date Performed: 10/12/2018
Date Collected: 10/12/2018 Complete: Final
Specimen:

Subject(Test Name): E.S.R (ESR-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

HAEMATOLOGY

Request Number 10289756 10809027 11744628 14721343
Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 10:45 14:45 12:05 15:36
Specimen Type: EDTA

ESR (< 30) mm/hr 2 2 5 2

Requested Tests : VBF*, UMM*, TFT*, TAA*, PRL*, PTH*, ESR, CRP*, CEA*, C19*, C15*, 125*, MBA*
FE*, FBE, DVI*, COR*

Patient Name: 

Patient Address; 
D.O.B: 24/09/1932 Gender: F
Medicare No.:  IHI No.:

Lab. Reference: 
Addressee: 

Date Requested: 10/12/2018 Date Performed: 10/12/2018

Date Collected: 10/12/2018 Complete: Final

Specimen:

Subject(Test Name): HAEMATOLOGY (FBE-0)
Clinical Information:

Clinical Notes : For review with elevated prolactin

HAEMATOLOGY
Request Number 10289756 10809027 11744628 14721343
Date Collected 12 Sep 17 8 Nov 17 30 Apr 18 10 Dec 18
Time Collected 10:45 14:45 12:05 15:36
Specimen Type: EDTA
Hb (115-165) g/L 141 125 141 130
Hct (0.34-0.47) 0.43 0.37 0.41 0.40
RCC (3.9-5.8) x10°12 /L 4.1 3.7 4.0 3.8
MCV (79-99) £L 104 103 102 105
MCH (27-34) pg 35 34 35 35
MCHC (320-360) g/L 332 334 347 329
RDW (10.0-17.0) $% 12.9 13.0 12.6 12.8
WBC (4.0-11.0) *10°9 /L 7.2 6.4 6.4 5.6
Neut (2.0-7.5) x10°9 /L 4.4 3.2 4.2 2.7
Lymph (1.0-4.0) x10*°9 /L 1.8 2.1 1.3 1.9
Mono (0.2-1.0) x10*9 38/L 0.7 0.7 0.6 0.7
Eos (< 0.7) x10*9) «=/L 0.2 0.3 0.3 0.2
Baso (< 0.2) x10*°9 /L 0.1 0.1 0.1 0.1
Plat (150-400) x10*9 /L 195 176 200 202

HAEMATOLOGY: Macrocytic blood picture.

Requested Tests : VBF*, UMM*, TFT*, TAA*, PRL*, PTH*, ESR*, CRP*, CEA*, C19*, C15*, 125*, MBA*,
FE*, FBE, DVI*, COR*
